SNAI2 and non-small cell lung carcinoma: NNT-AS1 via MAPK/Slug pathway could be involved in cisplatin chemoresistance in NSCLC. Interfering in the expression of NNT-AS1 could promote the cell cycle arrest of drug-resistant cells.